Brief Advice, Nicotine Replacement Therapy Sampling and Active Referral (BANSAR) for Smoking Fathers

Summary

This study aims to evaluate the effects of a combined "cocktail", cessation intervention of brief advice, nicotine replacement therapy sampling and active referral (BANSAR) for smoking expectant fathers on smoking cessation outcomes

Conditions

• Smoking Cessation
• Tobacco Use Cessation

Interventions

BEHAVIORAL

Brief AWARD advice

Subject will receive brief, face-to-face counselling following a structured AWARD model at baseline : 1. Ask: smokers will be asked about their smoking behaviour 2. Warn about the harms of smoking using a leaflet which contain information about harms of secondhand smoke to women, fetus and infant, motivational messages to quit and smoking cessation services. 3. Advise to quit or reduce their smoking and use the provided 1-week nicotine replace therapy sample as soon as possible 4. Refer smokers to smoking cessation services if they agree. 5. Do-it-again: repeat the AWARD advise through telephone boosters at 2-week and 4-week after baseline

DRUG

Nicotine replacement therapy sampling

Subjects will receive 1-week supply of free nicotine patch or gum with dosage based on participants' number of cigarette per day. An information card containing reminders of nicotine replacement therapy use and actions to handle potential side effects will be provided.

BEHAVIORAL

Active referral

Subjects will be encouraged to select and access a smoking cessation services in Hong Kong. If the subjects agree, their contact information will be sent to the smoking cessation service providers for further arrangement.

BEHAVIORAL

Very brief advice

Subjects will receive general advice to quit

BEHAVIORAL

Leaflet

Subjects will receive a standard leaflet on perinatal smoking by Department of Health

Sponsors & Collaborators

• Food and Health Bureau, Hong Kong

  collaborator OTHER_GOV

• Queen Mary Hospital, Hong Kong

  collaborator OTHER

• Pamela Youde Nethersole Eastern Hospital

  collaborator OTHER

• Kwong Wah Hospital

  collaborator OTHER

• Queen Elizabeth Hospital, Hong Kong

  collaborator OTHER

• United Christian Hospital

  collaborator OTHER

• Princess Margaret Hospital, Hong Kong

  collaborator OTHER_GOV

• Tuen Mun Hospital

  collaborator OTHER_GOV

• The University of Hong Kong

  lead OTHER

Principal Investigators

• Man Ping Wang, PhD · The University of Hong Kong

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

MALE

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2018-10-10

Primary Completion

2020-10-31

Completion

2020-12-31

Countries

• Hong Kong

Study Locations